Beam On
The Evidence and Rationale for a Coronary Brachytherapy Dose-Response
Jana Kobeissi, a 4th-year medical student at the American University of Beirut, talks with Kent Wallner, MD, a brachytherapy expert at UW Medicine, about coronary brachytherapy’s pathophysiology, target and dose uncertainties, dose response considerations, collaboration challenges, and future.
Wallner K, Kim M, Kearney KE, et al. The evidence and rationale for a coronary brachytherapy dose-response. Appl Radiat Oncol. 2022;11(3):18-26.
https://appliedradiationoncology.com/articles/the-evidence-and-rationale-for-a-coronary-brachytherapy-dose-response
Jana Kobeissi, a 4th-year medical student at the American University of Beirut, talks with Kent Wallner, MD, a brachytherapy expert at UW Medicine, about coronary brachytherapy’s pathophysiology, target and dose uncertainties, dose response considerations, collaboration challenges, and future.
Wallner K, Kim M, Kearney KE, et al. The evidence and rationale for a coronary brachytherapy dose-response. Appl Radiat Oncol. 2022;11(3):18-26.
https://appliedradiationoncology.com/articles/the-evidence-and-rationale-for-a-coronary-brachytherapy-dose-response